Search

Search Results

• Characteristic Features of COVID-19 and Opportunities for Its Prevention in Multiple Myeloma Patients

  Darya Aleksandrovna Chebykina, I.I. Krobinets

  96-103

  01.01.2026

• The Optimal Background Cut-Off Threshold for Calculating Volumetric PET Biomarkers as Prognostic Factors in Classical Hodgkin Lymphoma

  Mariya Vasilevna Metelkina, I.P. Aslanidi, O.V. Mukhortova, D.M. Pursanova, V.A. Manukova, I.V. Shurupova, T.A. Trifonova, D.D. Zubkov, A.S. Rumyantsev

  39-48

  01.01.2026

• Analysis of Plasma Circulating Cell-Free DNA in Acute Myeloid Leukemia Patients

  Elena Nikolaevna Voropaeva, M.V. Burundukova, I.A. Kuznetsova, P.S. Orlov, A.M. Nesterets, S.V. Minnikh, V.N. Maximov, T.I. Pospelova

  347-354

  01.10.2025

• Determination of the Minimal Residual Disease Threshold in Acute Myeloid Leukemia Treated with ‘ОМЛ-17’ and ‘mОМЛ-17’ Regimens

  Irina Vladimirovna Galtseva, E.N. Parovichnikova, K.A. Nikiforova, Yu.O. Davydova, N.M. Kapranov, I.A. Lukianova, A.A. Ievleva, Yu.A. Chabaeva, Z.T. Fidarova, L. A. Kuzmina, V.V. Troitskaya, T.V. Gaponova, S.M. Kulikov

  340-346

  01.10.2025

• DNA Methylation Genes in Multiple Myeloma: What We Already Know and How It Can Be Used?

  Daria Aleksandrovna Chebykina, E.V. Motyko, A.N. Kirienko, D.V. Kustova, O.B. Krysiuk, S.V. Sidorkevich, I.S. Martynkevich

  315-325

  01.10.2025

• The Prognostic Value of Minimal Residual Disease Assessed During the Remission Induction Stage in Acute Myeloid Leukemia Patients

  Irina Vladimirovna Galtseva, E.N. Parovichnikova, Yu.O. Davydova, N.M. Kapranov, K.A. Nikiforova, Yu.A. Chabaeva, L.A. Kuzmina, I.A. Lukianova, V.V. Troitskaya, T.V. Gaponova, S.M. Kulikov

  233-241

  01.07.2025

• Myeloid Sarcoma with Skin and Spinal Lesions and KRAS Gene Mutation, Complicated by Secondary Hemophagocytic Syndrome: A Case Report and Literature Review

  Tatyana Nikolaevna Tolstykh, O.L. Kochneva, E.N. Misyurina, E.A. Baryakh, M.A. Mingalimov, K.V. Yatskov, S.A. Kardovskaya, D.D. Ivanova, T.S. Chudnova, D.V. Lebedev, A.N. Titova, E.I. Zhelnova

  242-249

  01.07.2025

• Comparative Assessment of Long-Term Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated Donors Registered in the Russian and International Databases for Hematologic Diseases

  Anastasiya Viktorovna Beynarovich, A.L. Alyanskii, K.S. Afanaseva, L.V. Fedorova, A.M. Chekalov, E.A. Bakin, N.E. Ivanova, A.A. Golovacheva, E.V. Babenko, M.A. Estrina, O.G. Smykova, Yu.Yu. Vlasova, E.V. Morozova, N.B. Mikhailova, A.G. Smirnova, S.N. Bondarenko, M.D. Vladovskaya, D.E. Pevtsov, A.A. Vitrishchak, I.S. Moiseev, A.D. Kulagin, L.S. Zubarovskaya, B.V. Afanasyev

  257-269

  01.07.2025

• Effectiveness of the Initial Escalation of Immunochemotherapy in Patients with High Risk MALT-Lymphoma: Pilot Study Results

  Anna Konstantinovna Smol’yaninova, N.G. Gabeeva, S.A. Tatarnikova, A.V. Belyaeva, A.M. Kovrigina, E.G. Gemdzhyan, E.E. Zvonkov

  338-348

  01.07.2025

• Bruton Tyrosine Kinase Inhibitors for the Treatment of Relapsed Mantle Cell Lymphoma Involving CNS: Two Case Reports and Literature Review

  Evgenii Olegovich Kunevich, N.N. Nemstsveridze, M.A. Mikhaleva, A.Yu. Kuvshinov, T.V. Ovchinnikova, E.V. Koryakina, S.V. Samarina, K.Yu. Krutikova, S.V. Sidorkevich, S.V. Voloshin

  184-196

  01.04.2025

• Diffuse Large B-Cell Lymphoma with High Risk of Central Nervous System Damage: A Literature Review, Prevention, Treatment, and Prognosis

  Selmi Faikovna Ramazanova, A.V. Arakelyan, A.A. Semenova, O.Yu. Baranova, D.N. Tupitsyna, M.Yu. Kichigina, I.Z. Zavodnova, E.V. Paramonova, A.S. Antipova, V.O. Shpirko, Yu.I. Klyuchagina, U.G. Koshkina, G.S. Tumyan

  51-64

  01.01.2025

• Treatment of Patients with Relapsed/Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Own Data and Literature Review

  Arman Vachakanovich Arakelyan, G.S. Tumyan, A.A. Semenova, M.Yu. Kichigina, I.Z. Zavodnova, D.N. Tupitsyna, E.V. Paramonova, A.S. Antipova, V.O. Shpirko, Yu.I. Klyuchagina, S.F. Ramazanova, U.G. Koshkina, I.S. Monin, N.M. Zolotaikina, G.D. Petrova, O.P. Trofimova, A.S. Subbotin, M.A. Senchenko, V.Yu. Kirsanov

  38-50

  01.01.2025

• PET/CT in Hematological Malignancies: What Has Been Achieved and What Remains to Be Done

  Aleksei Sergeevich Subbotin, A.I. Pronin, T.M. Geliashvili, P.E. Tulin, T.S. Basova, B.M. Khakulova, G.S. Tumyan, A.A. Semenova

  109-128

  01.04.2024

• Nivo-BeGEV as Preparation for Autologous Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Classical Hodgkin Lymphoma: Results of a Multi-Center Prospective Clinical Study

  Yana Konstantinovna Mangasarova, T.N. Moiseeva, O.V. Margolin, L.G. Gorenkova, E.S. Nesterova, F.E. Babaeva, M.O. Bagova, E.A. Fastova, R.R. Abdurashidova, L.S. Al-Radi, E.I. Dorokhina, E.M. Volodicheva, V.A. Lapin, O.S. Samoilova, S.K. Kravchenko, A.U. Magomedova, E.E. Zvonkov

  280-286

  09.06.2023

• KIR-Genetic Factors and Response to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia

  Elena Vital’evna Kuzmich, I.E. Pavlova, L.N. Bubnova, S.S. Bessmeltsev

  119-127

  03.03.2023

• Plasma Cell-Free DNA in Patients with Diffuse Large B-Cell and B-Cell High-Grade (Double Hit/Triple Hit) Lymphomas

  Svetlana Yurevna Smirnova, E.E. Nikulina, N.G. Gabeeva, D.A. Koroleva, S.A. Tatarnikova, A.K. Smol’yaninova, E.G. Gemdzhian, E.E. Zvonkov, A.B. Sudarikov

  200-208

  03.03.2023

• Monitoring of Red Cell Donor Chimerism in Oncohematological Patients After Allogeneic Hematopoietic Stem Cell Transplantation

  Mariya Viktorovna Smolnikova, E.V. Butina, A.V. Iovdii, E.A. Poponina, N.A. Zorina

  96-100

  01.01.2023

• Quality of Life and Efficacy of Triplet IxaRd Therapy in Relapsed/Refractory Multiple Myeloma: Results of a Multi-Center Pilot Real-World Study

  T.I. Ionova, O.Yu. Vinogradova, Yu.B. Kochkareva, E.E. Markova, K.D. Kaplanov, M.N. Shirokova, T.V. Shelekhova, A.N. Levanov, A.V. Kopylova, O.Yu. Li, T.A. Mitina, O.A. Rukavitsyn, P.I. Simashova, L.V. Anchukova, E.N. Babich, S.A. Volkova, D.B. Dasheeva, M.V. Demchenkova, S.K. Dubov, T.V. Esenina, L.E. Ivanova, T.L. Kravchuk, E.V. Rimashevskaya, M.T. Savinova, N.O. Saraeva, N.M. Porfirieva, Tatyana Pavlovna Nikitina, V.V. Ptushkin

  240-252

  01.07.2022

• Efficacy and Safety of Midostaurin Combined with Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia with FLT3 Mutation

  Sergei Nikolaevich Bondarenko, A.G. Smirnova, B.I. Ayubova, E.V. Karyagina, O.S. Uspenskaya, Yu.S. Neredko, A.P. Kochergina, I.A. Samorodova, E.A. Pashneva, Yu.S. Chernykh, Yu.A. Dunaev, N.B. Esef’eva, R.K. Il’yasov, T.I. Brazhkina, I.A. Novokreshchenova, Z.K. Simavonyan, E.I. Kuzub, V.I. Bakhtina, T.I. Olkhovich, M.V. Burundukova, E.V. Babenko, Yu.D. Oleinikova, I.M. Barkhatov, T.L. Gindina, I.S. Moiseev, A.D. Kulagin

  167-175

  01.04.2022

• Protocol ALL-IC BFM 2002: Outcomes of Pediatric Acute Lymphoblastic Leukemia Treatment under Multi-Center Clinical Trial

  Timur Teimurazovich Valiev, M.A. Shervashidze, I.V. Osipova, T.I. Burlutskaya, N.A. Popova, N.S. Osmulskaya, G.A. Aleskerova, S.L. Sabantsev, Z.S. Gordeeva, V.Yu. Smirnov, O.A. Poberezhnaya, S.N. Yuldasheva, I.A. Babich, N.A. Batmanova, S.R. Varfolomeeva

  119-129

  01.04.2022

• Plasmablastic Lymphoma in HIV-Positive Patients: A Literature Review and Results of a Russian Multi-Center Retrospective Study

  Marina Olegovna Popova, I.V. Tsygankov, Ya.V. Gudozhnikova, Yu.A. Rogacheva, N.P. Volkov, K.V. Lepik, M.V. Demchenkova, M.V. Grigoreva, A.Yu. Efirkina, T.V. Shneider, Yu.V. Kopeikina, S.A. Stepanova, V.G. Potapenko, A.V. Klimovich, N.V. Medvedeva, M.A. Kolesnikova, T.I. Pospelova, N.B. Mikhailova, V.V. Baikov, A.D. Kulagin

  28-41

  01.01.2022

• Prediction of Treatment Efficacy in Relapsed Chronic Lymphocytic Leukemia

  Olga Borisovna Kalashnikova, I.S. Moiseev, T.L. Gindina, E.A. Izmailova, M.O. Ivanova, E.V. Kondakova, N.B. Mikhailova, A.D. Kulagin

  466-476

  01.10.2021

• Efficacy, Safety, and Tolerance of Gemtuzumab Ozogamicin Combined with FLAG/FLAG-Ida or Azacitidine in Relapsed/Refractory Acute Myeloblastic Leukemia

  Irina Garmaevna Budaeva, D.V. Zaitsev, A.A. Shatilova, E.N. Tochenaya, A.V. Petrov, R.I. Vabishchevich, D.V. Motorin, R.Sh. Badaev, D.B. Zammoeva, V.V. Ivanov, S.V. Efremova, K.V. Bogdanov, Yu.V. Mirolyubova, T.S. Nikulina, Yu.A. Alekseeva, A.Yu. Zaritskey, L.L. Girshova

  299-307

  01.07.2021

• Multiple Myeloma and Dendritic Cell Vaccines

  Irina Vladimirovna Gribkova, A.A. Zavyalov

  370-377

  01.07.2021

• Use of Blinatumomab in Acute Lymphoblastic Leukemia in Municipal Healthcare: A Case Report

  Vasilii Anatolevich Shuvaev, O.V. Ushakova, E.I. Mullo, T.V. Tolstykh, N.Z. Triputen

  198-203

  01.04.2021

• Retrospective Survival Analysis of Multiple Myeloma Patients after Autologous Hematopoietic Stem Cell Transplantation

  Ivan Ivanovich Kostroma, A.A. Zhernyakova, I.M. Zapreeva, Zh.Yu. Sidorova, N.Yu. Semenova, E.V. Karyagina, E.I. Stepchenkova, S.S. Bessmeltsev, A.V. Chechetkin, S.V. Gritsaev

  73-79

  01.01.2021

• Factors for Sustaining Molecular Remission after Discontinuation of Tyrosine Kinase Inhibitors Therapy in Chronic Myeloid Leukemia: Results of Non-Randomized Prospective Clinical Trial

  Oleg Aleksandrovich Shukhov, A.N. Petrova, E.Yu. Chelysheva, A.V. Bykova, I.S. Nemchenko, A.G. Turkina

  1-12

  01.01.2021

• CAR T-Cell Therapy with NKG2D Chimeric Antigen Receptor in Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome

  Kseniya Aleksandrovna Levchuk, E.V. Belotserkovskaya, D.Yu. Pozdnyakov, L.L. Girshova, A.Yu. Zaritskey, A.V. Petukhov

  138-148

  01.01.2021

• Chronic Lymphocytic Leukemia in Blood Relatives: Two Case Reports of Male Siblings

  Nadezhda Viktorovna Kurkina, E.A. Repina

  69-72

  01.01.2021

• Checkpoint Inhibitors and Classical Hodgkin’s Lymphoma: Efficacy and Safety of Pembrolizumab in Relapsed/Refractory Tumor (Experience at the NI Pirogov Russian National Medical Center of Surgery)

  Vladislav Olegovich Sarzhevskii, E.A. Demina, N.E. Mochkin, A.A. Spornik, A.A. Mamedova, E.G. Smirnova, A.E. Bannikova, A.A. Samoilova, V.S. Bogatyrev, V.Ya. Melnichenko

  53-62

  01.01.2021

• Comorbidity and Personalized Treatment of Multiple Myeloma in Real Clinical Practice

  Nataliya Valer’evna Skvortsova, I.B. Kovynev, K.V. Khalzov, T.I. Pospelova, I.N. Nechunaeva

  322-334

  01.07.2020

• Long-Term Outcomes of Nivolumab Therapy in Patients with Relapsed/Refractory Classic Hodgkin’s Lymphoma after High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Real Clinical Practice

  Kirill Viktorovich Lepik, N.P. Volkov, N.B. Mikhailova, E.V. Kondakova, L.A. Tsvetkova, Yu.R. Zalyalov, E.E. Lepik, L.V. Fedorova, A.V. Beinarovich, M.V. Demchenkova, O.G. Smykova, P.V. Kotselyabina, I.S. Moiseev, V.V. Baikov, B.V. Afanasyev

  280-288

  01.07.2020

• Primary Bone Lymphomas: 18F-FDG PET and PET-CT as Methods of Diagnosis and Efficacy Estimation of Antitumor Treatment

  Anna Konstantinovna Smol’yaninova, E.R. Moskalets, G.A. Yatsyk, I.E. Kostina, A.S. Bogolyubskaya, N.G. Gabeeva, E.G. Gemdzhian, S.A. Tatarnikova, D.S. Badmadzhapova, E.E. Zvonkov

  33-49

  01.01.2020

• TP53 Gene Mutations in Tumor Cells of Patients with Aggressive B-Cell Lymphomas

  Anna Evgen’evna Misyurina, S.K. Kravchenko, V.A. Misyurin, A.M. Kovrigina, A.U. Magomedova, E.A. Baryakh, F.E. Babaeva, A.V. Misyurin

  263-270

  01.07.2019

• Prediction of FLAG ± Ida Regimen Efficacy in Patients with Relapsed/Refractory Acute Myeloid Leukemia

  Irina Garmaevna Budaeva, E.G. Ovsyannikova, E.N. Goryunova, O.V. Kulemina, D.V. Zaitsev, D.V. Motorin, R.Sh. Badaev, D.B. Zammoeva, V.V. Ivanov, K.V. Bogdanov, O.S. Pisotskaya, Yu.V. Mirolyubova, T.S. Nikulina, Yu.A. Alekseeva, A.Yu. Zaritskey, L.L. Girshova

  289-296

  01.07.2019

• Rearrangement of Immunoglobulin Genes in Tumor Cells of Patients with Primary Mediastinal (Thymic) Large B-Cell Lymphoma

  Yana Konstantinovna Mangasarova, Yu.V. Sidorova, A.U. Magomedova, B.V. Biderman, E.E. Nikulina, A.B. Sudarikov, A.M. Kovrigina, S.K. Kravchenko

  271-277

  01.07.2019

• Clinical Value of miR-3151 Overexpression in Synergistic Interaction with BAALC Host Gene in Patients with Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

  Alena Igorevna Shakirova, I.M. Barkhatov, A.I. Churkina, N.N. Mamaev, L.S. Zubarovskaya, B.V. Afanas’ev

  303-308

  01.07.2019

• The Use of Ibrutinib in Refractory Chronic Lymphocytic Leukemia and in High-Risk Patients

  Nadezhda Viktorovna Kurkina, E.A. Repina, N.N. Mashnina

  278-281

  01.07.2019

• Severe Hypofunction of Allogeneic Hematopoietic Stem Cell Transplant in Patients with Oncohematological Diseases: Incidence, Risk Factors, and Outcomes

  Tat’yana Aleksandrovna Rudakova, A.D. Kulagin, O.U. Klimova, I.K. Golubovskaya, E.I. Darskaya, T.A. Bykova, A.G. Smirnova, E.V. Morozova, S.N. Bondarenko, I.S. Moiseev, A.V. Beinarovich, D.E. Pevtsov, A.L. Alyanskii, E.V. Babenko, I.M. Barkhatov, B.V. Afanas’ev

  309-318

  01.07.2019

• Overcoming Resistance in Relapsed Anaplastic Large-Cell Lymphoma, ALK-Positive (Literature Review and Clinical Experience)

  Yuliya Eikhenovna Vinogradova, N.G. Chernova

  179-184

  01.04.2019